Published in Hum Genet on November 01, 1994
Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO J (1995) 1.73
Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema. Am J Hum Genet (1996) 1.04
C1 inhibitor: molecular and clinical aspects. Springer Semin Immunopathol (2005) 0.96
Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease. J Biol Chem (2014) 0.86
Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol (1990) 10.23
The detection of venous thrombosis of the legs using 125-I-labelled fibrinogen. Br J Surg (1968) 10.22
Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol (1992) 8.25
The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet (1992) 8.20
Human gene mutation database-a biomedical information and research resource. Hum Mutat (2000) 6.87
Natural history of postoperative deep-vein thrombosis. Lancet (1969) 5.18
An estimate of unique DNA sequence heterozygosity in the human genome. Hum Genet (1985) 4.75
125-I-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis. Lancet (1970) 4.48
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med (1999) 4.33
Galectins. Structure and function of a large family of animal lectins. J Biol Chem (1994) 4.29
Galectins: a family of animal beta-galactoside-binding lectins. Cell (1994) 3.99
Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet (1991) 3.48
Neighboring-nucleotide effects on the rates of germ-line single-base-pair substitution in human genes. Am J Hum Genet (1998) 3.12
DNA restriction fragment length polymorphisms and heterozygosity in the human genome. Hum Genet (1984) 2.79
Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis. Lancet (1976) 2.77
The human gene mutation database. Trends Genet (1997) 2.72
Deep vein thrombosis of the leg. Is there a "high risk" group? Am J Surg (1970) 2.66
Unmethylated domains in vertebrate DNA. Nucleic Acids Res (1983) 2.58
Low doses of heparin in prevention of deep-vein thrombosis. Lancet (1971) 2.38
Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet (1997) 2.37
Human Gene Mutation Database: towards a comprehensive central mutation database. J Med Genet (2008) 2.37
Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med (2001) 2.31
Regional mapping of six cloned DNA sequences on human chromosome 7. Am J Hum Genet (1986) 2.26
Report of the DNA committee and catalogues of cloned and mapped genes and DNA polymorphisms. Cytogenet Cell Genet (1990) 2.21
Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery. A double-blind, randomised trial. Lancet (1972) 2.20
Postoperative deep-vein thrombosis. Effect of intensive prophylaxis. Lancet (1969) 2.09
A physiological study of elastic compression stockings in venous disorders of the leg. Br J Surg (1980) 2.06
Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J Biol Chem (1989) 2.05
The origin of deep vein thrombosis: a venographic study. Br J Radiol (1971) 1.96
Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin. Br Med J (1969) 1.82
Discoidin I is implicated in cell-substratum attachment and ordered cell migration of Dictyostelium discoideum and resembles fibronectin. Cell (1984) 1.82
Human gene cloning: the storm before the lull? Nature (1986) 1.78
Late results of treatment of deep vein thrombosis. Br Med J (1969) 1.77
The factor VIII Structure and Mutation Resource Site: HAMSTeRS version 4. Nucleic Acids Res (1998) 1.66
A new pathway for protein export in Saccharomyces cerevisiae. J Cell Biol (1996) 1.66
The origin of thrombi in the deep veins of the lower limb: a venographic study. Br J Surg (1978) 1.65
Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. Am J Cardiol (1996) 1.64
Sugar intake, serum insulin and platelet adhesiveness in men with and without peripheral vascular disease. Postgrad Med J (1969) 1.63
Cold adaptation and the seasonal distribution of acute myocardial infarction. QJM (1999) 1.62
Efflux of radiolabeled polyethylene glycols and albumin from rat brain. Am J Physiol (1981) 1.62
Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet (2000) 1.61
Evaluation of Simulated Presence: a personalized approach to enhance well-being in persons with Alzheimer's disease. J Am Geriatr Soc (1999) 1.59
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Eukaryotic DNA methylation. Hum Genet (1983) 1.57
Serotypes and electropherotypes of human rotavirus in the USA: 1987-1989. J Infect Dis (1990) 1.54
Diagnosis of genetic disease using recombinant DNA. Supplement. Hum Genet (1987) 1.50
L-29, an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity. Biochemistry (1993) 1.47
p53 mutations, benzo[a]pyrene and lung cancer. Mutagenesis (1998) 1.47
Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin. Br J Haematol (1995) 1.47
Relationship between asthma and gastro-oesophageal reflux. Thorax (1981) 1.45
Heparin-induced thrombocytopenia thrombosis after cardiac surgery. A case report. Acta Anaesthesiol Scand (2000) 1.44
Late-onset homozygous protein C deficiency. Lancet (1991) 1.43
Trimethoprim and amoxycillin in acute otitis media. Practitioner (1985) 1.43
Validity of D-dimer tests in the diagnosis of deep vein thrombosis: a prospective comparative study of three quantitative assays. J Intern Med (2002) 1.42
Lipid peroxides and atherosclerosis. BMJ (1989) 1.41
Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy. Am J Cardiol (1993) 1.40
[Hemophilia. Treatment of bleeders and the significance of their social situation]. Ugeskr Laeger (1992) 1.39
Influence of whole blood on standard curve for heparin measurement--possible heparin binding by red cells. Thromb Haemost (1989) 1.39
The effect of low molecular weight heparin on intimal hyperplasia in vein grafts. Eur J Vasc Surg (1994) 1.39
Adult-onset genetic disease: mechanisms, analysis and prediction. QJM (1997) 1.39
Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting. Lancet (1994) 1.39
Lung function test findings in patients with chronic fatigue syndrome (CFS) Aust N Z J Med (1996) 1.39
Fibrinolytic activity and postoperative deep-vein thrombosis. Lancet (1974) 1.39
An objective study of alternative methods of heparin administration. Thromb Res (1980) 1.38
Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement. Lancet (1976) 1.38
Review of present status of prophylaxis of venous thromboembolism. Proc R Soc Med (1974) 1.37
The molecular genetics of growth hormone deficiency. Hum Genet (1998) 1.33
Myocardial infarction and deep-vein thrombosis. Br Med J (1971) 1.33
Acquired dysfibrinogenaemia in acute and chronic liver disease. Br J Haematol (1977) 1.30
Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet (1998) 1.29
Plasma exchange and platelet function in Raynaud's phenomenon. Thromb Res (1981) 1.28
Localization of a human heat-shock HSP 70 gene sequence to chromosome 6 and detection of two other loci by somatic-cell hybrid and restriction fragment length polymorphism analysis. Hum Genet (1987) 1.28
Restriction fragment length polymorphisms at the human parathyroid hormone gene locus. Hum Genet (1984) 1.27
Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene. Nucleic Acids Res (1991) 1.26
Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients. J Med Genet (2005) 1.26
Endotoxaemia and renal failure in cirrhosis and obstructive jaundice. Br Med J (1976) 1.25
Characteristics of closeness in adolescent romantic relationships. J Adolesc (2001) 1.23
The changing pattern of venous thromboembolic disease. Haemostasis (1997) 1.23
Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. J Med Genet (2010) 1.23
Disease-causing mutations in the human genome. Eur J Pediatr (2000) 1.22
Human gene cloning and disease analysis. Lancet (1987) 1.22
Diagnosis of genetic disease using recombinant DNA. Hum Genet (1986) 1.20
D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection. Neurology (2003) 1.20
Graduated, static, external compression of the lower limb: a physiological assessment. Br J Surg (1980) 1.18
Deep vein thrombosis after elective knee surgery. An incidence study in 312 patients. J Bone Joint Surg Br (1989) 1.18
Deep-vein thrombosis in patients with fractures of the femoral neck. Br J Surg (1972) 1.18
beta-thromboglobulin and platelet factor 4 levels in retinal vein occlusion. Br J Ophthalmol (1983) 1.16
Discrimination between recurrent mutation and identity by descent: application to point mutations in exon 11 of the cystic fibrosis (CFTR) gene. Hum Genet (1991) 1.16
Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis. Br Med J (Clin Res Ed) (1982) 1.16
Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost (1997) 1.15
Evaluation of genotype-phenotype correlations in neurofibromatosis type 1. J Med Genet (2003) 1.15
Human type I hair keratin pseudogene phihHaA has functional orthologs in the chimpanzee and gorilla: evidence for recent inactivation of the human gene after the Pan-Homo divergence. Hum Genet (2001) 1.15
Physical violence, self rated health, and morbidity: is gender significant for victimisation? J Epidemiol Community Health (2004) 1.14
Somatic spectrum of cancer-associated single basepair substitutions in the TP53 gene is determined mainly by endogenous mechanisms of mutation and by selection. Hum Mutat (1995) 1.12
Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium. Arterioscler Thromb Vasc Biol (1997) 1.11